Appointment - Aymeric Bordet (SKEMA 2008) is appointed Chief Financial Officer of Aurobac Therapeutics

19 September 2025

Aymeric Bordet (SKEMA 2008) is appointed Chief Financial Officer of Aurobac Therapeutics.

Aymeric has completed the following career path:

* 2025 - ... : Aurobac Therapeutics, Chief Financial Officer

Partner

* 2024 - 2025 : Allogenica, Chief Financial Officer

* 2021 - 2022 : Benefiz, Chief Financial Officer

* 2021 - 2023 : TransCure bio service, CFO (part time)

Celine Da Silva (SKEMA 2003) is promoted to Group Strategy...

Celine DA SILVA...

Notebook